#United States #Clinical Trials #Schaumburg #Remote Patient Monitoring #HeartcoR Solutions

HeartcoR Solutions Expands Remote Patient Monitoring Devices

HeartcoR Solutions, a prominent core lab dedicated to advancing cardiac safety and physiological data collection in clinical trials, has recently announced a significant expansion of its remote patient monitoring (RPM) technology offerings. The integration of innovative devices from Blue Spark Technologies, Inc. and QT Medical promises to establish HeartcoR as a comprehensive resource for clinical trial sponsors.

Enhancing Clinical Trials through Innovation

With the growing demand for patient-centered healthcare, the pharmaceutical and medical device sectors are increasingly seeking remote monitoring solutions to gather vital data regarding the safety and efficacy of novel therapies. Ciaran Cooper, CEO of HeartcoR Solutions, emphasized the importance of these advancements in clinical trials, stating, "Healthcare innovation relies on the ability to prove the safety and efficacy of new medical devices and therapeutics. By expanding our suite of remote monitoring devices, we're empowering clinical trial sponsors to save time and streamline workflows."

New Collaborations

The announcement details the addition of two notable devices: the TempTraq® from Blue Spark Technologies and the PCA 500 from QT Medical. Each device offers distinct capabilities that enhance the overall monitoring process, making it easier for clinical trial sponsors to meet their research needs.

1. TempTraq®: This FDA-cleared, one-time-use device provides continuous, real-time monitoring of body temperature. With an operational span of 72 hours, it connects via Bluetooth, allowing patients to maintain mobility while being monitored. The data collected can be seamlessly integrated with electronic health records (EHRs), enriching the clinical trial data pool.

2. PCA 500: This portable, hospital-quality device delivers 12-lead ECGs, which patients can easily use at home or during clinical trial testing. The PCA 500 kit includes a compact recorder, preconnected electrode strips, a user-friendly mobile app, and a secure cloud dashboard for efficient data management. Its lightweight design and wireless capabilities facilitate easy data acquisition.

The Future of Remote Patient Monitoring

The global RPM market is forecasted to grow at an impressive compound annual growth rate (CAGR) of 19.8% from 2025 to 2033, reflecting the rising adoption of innovative monitoring devices. As more clinical trial sponsors recognize the importance of remote monitoring, HeartcoR Solutions aims to facilitate better access to these technologies, ultimately improving the quality of data collected, streamlining processes, and reducing overall trial costs.

Cooper reiterated HeartcoR's commitment to fostering medical innovation, stating, "By expanding our technology suite with cutting-edge devices that are patient-centered and proven to deliver high-quality, reliable data, we're doing just that."

Conclusion

To learn more about the expanded offerings of HeartcoR Solutions or to discuss specific clinical trial needs, interested parties can visit www.HeartcoRSolutions.com. As a leading core lab in the Chicago area, HeartcoR is poised to redefine remote patient monitoring and enhance the efficiency of clinical trials.

This latest initiative positions HeartcoR Solutions at the forefront of the RPM landscape, helping to meet the healthcare sector's ever-growing demands.